Cantor Fitzgerald Initiates Coverage On LeMaitre Vascular with Neutral Rating, Announces Price Target of $96

Benzinga · 10/15 11:23
Cantor Fitzgerald analyst Ross Osborn initiates coverage on LeMaitre Vascular (NASDAQ:LMAT) with a Neutral rating and announces Price Target of $96.